Reuters logo
BRIEF-Pernix Therapeutics Holdings expects Q2 revenues to be between $33 mln and $35 mln
July 20, 2017 / 9:00 PM / 2 months ago

BRIEF-Pernix Therapeutics Holdings expects Q2 revenues to be between $33 mln and $35 mln

July 20 (Reuters) - Pernix Therapeutics Holdings Inc

* Pernix Therapeutics pre-announces certain preliminary second quarter 2017 financial results

* Sees Q2 2017 revenue $33 million to $35 million

* Sees Q2 2017 revenue down 5 to 10 percent

* Pernix Therapeutics Holdings Inc says Q2 2017 net revenues are expected to be between $33.0 million and $35.0 million

* Pernix Therapeutics Holdings Inc - ‍Net loss for Q2 of 2017 is expected to be between $20.5 million and $24.5 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below